Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early Phase 2 Trial of KW-6356 in Early Parkinson's Disease
jRCT2080223340Phase 2
- Sponsor
- Kyowa Kirin
- Start
- Oct 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Parkinson's disease (PD) comparing KW-6356 with Placebo (2 arms).
02
Drugs
sipagladenant
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on jRCT2080223340.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223340.